Curis (CRIS) Asset Utilization Ratio (2011 - 2026)
Curis' (CRIS) quarterly Asset Utilization Ratio came in at 0.28 in Q1 2026, up 2.34% YoY from 0.28 in Q1 2025, and down 28.28% on a QoQ basis from 0.4 in Q4 2025.
Curis (CRIS) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
Curis (CRIS) has 16 years of Asset Utilization Ratio data on file, last reported at 0.28 in Q1 2026.
- Quarterly Asset Utilization Ratio rose 2.34% year-over-year to 0.28 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.28 (up 2.34% YoY) and the FY2025 annual result came in at 0.31, up 67.6% from the prior year.
- Asset Utilization Ratio fell to 0.28 in Q1 2026, from 0.4 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.41 in Q3 2025 to a low of 0.07 in Q1 2022.
- A 5-year average of 0.19 and a median of 0.14 in 2024 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2024 — Asset Utilization Ratio soared 117.37% — and 2026, when it climbed 2.34%.
- Tracing CRIS's Asset Utilization Ratio over 5 years: stood at 0.09 in 2022, then jumped by 36.64% to 0.12 in 2023, then soared by 117.37% to 0.26 in 2024, then jumped by 52.27% to 0.4 in 2025, then decreased by 28.28% to 0.28 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.28 (Q1 2026), 0.4 (Q4 2025), and 0.41 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 0.90 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.13 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.54 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.13 |
| 10 | Curis | 3.27 Mn | -2.35 Mn | - | 0.18 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.28 |
| Dec 31, 2025 | 0.40 |
| Sep 30, 2025 | 0.41 |
| Jun 30, 2025 | 0.33 |
| Mar 31, 2025 | 0.28 |
| Dec 31, 2024 | 0.26 |
| Sep 30, 2024 | 0.22 |
| Jun 30, 2024 | 0.18 |
| Mar 31, 2024 | 0.14 |
| Dec 31, 2023 | 0.12 |
| Sep 30, 2023 | 0.12 |
| Jun 30, 2023 | 0.11 |
| Mar 31, 2023 | 0.10 |
| Dec 31, 2022 | 0.09 |
| Sep 30, 2022 | 0.08 |
| Jun 30, 2022 | 0.08 |
| Mar 31, 2022 | 0.07 |
| Dec 31, 2021 | 0.06 |
| Sep 30, 2021 | 0.06 |
| Jun 30, 2021 | 0.06 |